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ABSTRACT
To implement appropriate and effective disease 
control programs at the national level, up-to-date and 
unbiased information on disease frequency is needed. 
The aim of this study was to estimate the prevalence 
of selected endemic infectious diseases in the popula-
tion of dairy herds in Great Britain. Bulk milk tank 
(BMT) samples from 225 randomly selected dairy 
farms, stratified by region and herd size, were tested for 
antibodies against bovine viral diarrhea virus (BVDV), 
bovine herpesvirus type 1, Mycobacterium avium ssp. 
paratuberculosis, Leptospira Hardjo, Salmonella spp., 
Coxiella burnetii, Fasciola hepatica, Neospora caninum, 
and Ostertagia ostertagi. Furthermore, the presence of 
BVDV, C. burnetii, and Chlamydia-like organisms was 
determined by PCR. The apparent herd prevalence was 
estimated as a weighted proportion of positive herds. 
The true prevalence was calculated when a test was 
used with known test characteristics for the cut-off value 
used. Among unvaccinated herds, the true prevalence of 
BMT antibodies against BVDV was estimated at 66% 
[95% confidence interval (CI): 56–77%], M. avium ssp. 
paratuberculosis 68% (95% CI: 59–77%), bovine herpes-
virus type 1 62% (95% CI: 52–73%), Leptospira Hardjo 
47% (95% CI: 34–60%), and Salmonella spp. 48% (95% 
CI: 39–56%). The apparent prevalence of BMT anti-
bodies against C. burnetii was 80% (95% CI: 75–85%), 
F. hepatica 55% (95% CI: 48–62%), N. caninum 46% 
(95% CI: 38–54%), and O. ostertagi 95% (95% CI: 
91–98%). The BVDV, C. burnetii, and Chlamydia-like 
antigens were detected in 5 (95% CI: 2–9%), 29 (95% 
CI: 21–36%), and 31% (95% CI: 24–38%) of herds, re-
spectively. Our results show that dairy cows across GB 
are frequently exposed to the studied pathogens, which 
are endemic at high levels with some geographical 
variations. These prevalence estimates provide a much-
needed basis to assess whether nationwide control pro-
grams for the studied pathogens are justified by their 
potential economic, environmental, and public health 
implications. Should surveillance and control programs 
be initiated, the estimates presented here are a baseline 
against which progress can be assessed.
Key words: prevalence, endemic infectious disease, 
dairy cow, bulk milk, ELISA
INTRODUCTION
Several infectious diseases of dairy cows such as 
bovine viral diarrhea virus (BVDV), Johne’s disease 
caused by Mycobacterium avium ssp. paratuberculosis 
(MAP), infectious bovine rhinotracheitis, and liver 
fluke are generally regarded as being widespread and 
endemic in the United Kingdom (Carslake et al., 2011; 
Sekiya et al., 2013). These diseases are known to have 
a significant effect on dairy production due to their ef-
fects on fertility (Fray et al., 2000; Lanyon et al., 2014; 
Walz et al., 2015), milk production (Tiwari et al., 2007; 
McAloon et al., 2016), and, subsequently, culling (Mur-
phy et al., 2006; Smith et al., 2010).
In Great Britain (GB) in 2005, the total costs of 
dairy and beef cattle endemic infectious diseases (dis-
ease, control, and prevention) were estimated to be as 
high as £10 million ($12.4 million) for Johne’s disease 
and £61.1 million ($75.7 million) per annum for BVDV 
(Bennett and Ijpelaar, 2005). However, due to a lack of 
reliable prevalence data at national level, these figures 
are likely to underestimate the true situation. With the 
exception of bovine tuberculosis in GB and BVDV in 
Scotland, controlling such diseases is voluntary for GB 
farmers. However, the need to control endemic infec-
tious disease can be overlooked by farmers, as it can be 
difficult to associate their presence with visible losses. 
This is often because clinical signs associated with 
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such diseases on a given animal in an infected herd are 
absent, mild, or nonspecific, leading to a general ac-
ceptance of their occurrence on dairy farms in endemic 
areas (Carslake et al., 2011; Statham, 2011). In such 
cases, from the farmers’ perspective, there is often very 
little, if any, financial incentive to control the disease 
(Stott et al., 2005). Nevertheless, examples from Euro-
pean countries suggest that the control or elimination 
of some of these pathogens [e.g., bovine herpesvirus 
type 1 (BHV-1) in Scandinavian countries and Aus-
tria, BVDV in Sweden] can be achieved and would be 
beneficial (Ackermann and Engels, 2006; Lindberg et 
al., 2006).
When control programs are implemented, it is impor-
tant that they are accompanied by continuous monitor-
ing of herd status to assess the effectiveness of the pro-
gram and progress toward goals; this can be achieved 
through serological testing at the herd level (Lindberg 
and Alenius, 1999; Houe et al., 2006). Testing of bulk 
milk samples is a particularly cost-effective strategy 
and has become part of surveillance and disease-control 
programs for several endemic infectious diseases of 
dairy cattle (Booth et al., 2013; Sekiya et al., 2013).
The application of a suitable disease control or elimi-
nation program at national or regional level and the 
monitoring of the progress of that program should be 
based on knowledge of the baseline frequency and dis-
tribution of the disease in the population (Ackermann 
and Engels, 2006; Humphry et al., 2012; Sayers et al., 
2015). Such estimates can allow informed decisions 
on the justification of a program at the national level 
and provide a baseline against which the effect of the 
control program can be assessed. With the exception 
of BVDV in Scotland, for which a survey of Scottish 
dairy farms has recently been carried out to inform 
the Scottish BVDV elimination program (Humphry et 
al., 2012), presently, in GB, there is a lack of reliable 
and up-to-date estimates of the prevalence of endemic 
diseases in the national dairy herd. This is because, 
for the majority of endemic diseases, no active disease 
surveillance is in place. Several private and public rou-
tine recording systems exist; however, at the national 
level, the information they provide is likely to be biased 
(Velasova et al., 2015).
In addition to these ongoing recording systems, one-
off surveys are often carried out (Davison et al., 2005; 
Salimi-Bejestani et al., 2005; Woodbine et al., 2009b); 
although useful, their results should be interpreted with 
caution because of issues such as nonprobabilistic selec-
tion of studied farms (Paton et al., 1998; Woodbine et 
al., 2009b; Williams and Winden, 2014) and failure to 
adjust prevalence estimates for the study design (Paton 
et al., 1998) or for test performance (Davison et al., 
2005; Woodbine et al., 2009a; Williams and Winden, 
2014). Furthermore, one-off studies are only useful for 
a limited period of time, as the prevalence can change 
as a result of the implementation of control measures 
and changes in the dairy industry, the more apparent 
of which are increased herd size, genetic selection, and 
application of new technological innovations (Barkema 
et al., 2015). It is therefore reasonable to assume that 
the few available estimated prevalence figures could no 
longer be accurate. Accordingly, the aim of our study 
was to generate new information on the prevalence and 
distribution of selected important infectious diseases of 
dairy cows at the national level to provide a basis for 
a future monitoring of disease trends over time and 
for the implementation of suitable and effective disease 
control or elimination programs at the national level.
MATERIALS AND METHODS
Study Population and Sampling Design
A nationwide, cross-sectional study of commercial 
dairy herds was conducted in GB from April 2014 to 
March 2015. The study population was selected by 
means of stratified random sampling from a sample 
frame comprising 10,491 dairy farms, representing ap-
proximately 95% of the total population of all dairy 
farms in GB, held by the dairy industry (AHDB Dairy, 
division of the Agricultural and Horticultural Develop-
ment Board). The registered farms were stratified by 
6 regions (north England, Midlands, southeast Eng-
land, southwest England, Scotland, and Wales) and 
then within each region by herd size (small: <50 cows; 
medium: 50–149 cows; large: ≥150 cows), creating 18 
strata. The herd size was based on the total number 
of lactating and dry cows. An equal number of farms 
within each stratum was selected using simple random 
sampling. The total number (n) of farms to study was 
calculated using ProMesa software v.1.62 (http:// www 
.promesa .co .nz/ ) according to the formula:
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where e is the number of strata, ni is the number of 
farms in stratum i (i.e., large farms in Scotland), pi is 
the expected prevalence in stratum i (50% was used as 
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worst-case scenario), N is the total number of farms in 
the population (10,491), AE is absolute acceptable error 
(error of 14% to achieve 7% precision for the assumed 
50% prevalence), 1.96 is the critical Z score value for a 
95% confidence interval, and wi is a weighting factor of 
each stratum. For purpose of sample size calculation, 
perfect sensitivity and specificity of the diagnostic tests 
were assumed. A total sample of 200 farms was found 
to be sufficient to generate the desired estimates, and it 
was decided to aim to recruit 250 farms (approximately 
40 farms from each region with approximately equal 
number of farms within each herd size category).
Based on previous experiences of the dairy industry, 
it was expected that around 20% of farmers contacted 
would be willing to participate in the study. The select-
ed farmers were contacted by post, receiving informa-
tion about the project and their participation. Farmers 
not responding to the initial letter received a reminder. 
Cattle veterinary practitioners were also informed 
about the project through the British Cattle Veteri-
nary Association newsletter and by email and were also 
asked to encourage their clients to participate if they 
received a letter inviting them. Farmers who agreed to 
participate were included in the study and the status of 
their farms with respect to 10 different pathogens was 
assessed. Selection of specific pathogens was based on 
the results of a workshop run by the Royal Veterinary 
College in April 2012. In the workshop, the participants 
were asked to identify and rank cattle health condi-
tions considered important for individual farmers and 
the dairy industry for which no reliable and up-to-date 
nationwide estimates were available (Velasova et al., 
2015). Additionally, 5 more pathogens for which no up-
to-date nationwide estimates were identified that could 
be detected using bulk milk samples and were included.
Ascertainment of Disease Status
Farm-level status with regard to BVDV, MAP, BHV-
1, Salmonella spp., Leptospira Hardjo, Coxiella burnetii, 
Fasciola hepatica, Neospora caninum, and Ostertagia 
ostertagi was assessed by testing a single or repeated 
bulk milk tank (BMT) samples for the presence of 
specific antibodies (Table 1). In addition, for 3 of the 
pathogens (BVDV, C. burnetii, and Chlamydia-like or-
ganisms), direct detection of the antigen in bulk milk 
was carried out.
From each farm, a BMT sample of approximately 30 
mL was collected and kept refrigerated until arrival at 
the laboratory. On arrival, fresh milk samples were put 
into refrigerated storage set at a temperature between 
1 and 7°C. To each sample, 5 mL of Bronopol (Wychem 
Ltd., Newmarket, UK) preservative was added. Com-
mercially available ELISA, described in Table 1, were Ta
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performed according to the manufacturers’ instructions. 
If an option for short and long incubation was avail-
able, the long incubation was used. The results were 
calculated according to the manufacturer’s instructions 
as (1) a sample-to-positive percentage calculated as the 
ratio of the optical density of the sample (ODS) minus 
the optical density of the negative control (ODNC) to 
the optical density of the positive control (ODPC) minus 
optical density of the negative control (ODNC) × 100, 
or as (2) the percentage inhibition, calculated as (1 − 
ODS/ODNC) × 100. One exception to the interpretation 
of the results was made; a positive cut-off value of 12.5 
instead of 30% S/P was used to identify MAP-positive 
herds, as described by van Weering et al. (2007).
The presence of BVDV antigen was studied by means 
of a real-time PCR protocol (TaqVet BVDV screening 
test, LSI, Lissieu, France). The presence of C. burnetii 
antigen was assessed by means of an in-house real-time 
PCR protocol developed by Klee et al. (2006). An in-
house real-time PCR (16S Chlamydiales PCR) accord-
ing to Lienard et al. (2011) was also used to detect 
Chlamydia-like organisms.
All the analyses were carried out on a single BMT 
sample with the exception of the detection of antibod-
ies against MAP and F. hepatica and the detection of 
BVDV antigen, which were carried out on 4 samples 
collected at an interval of once every 3 mo. This was 
carried out to increase the detection of positive farms 
considering the low sensitivity of bulk milk ELISA tests 
for the detection of MAP (van Weering et al., 2007) 
and F. hepatica (Reichel et al., 2005) and higher preva-
lence of BVDV among young stock (Booth et al., 2013).
Data Collection
A standardized questionnaire was used to gather 
information on general farm characteristics (i.e., herd 
size, production type), vaccination status, the main 
herd health problems as perceived by the farmer at 
the time of the visit, and the farmer’s knowledge of the 
disease status of the farm for each disease in question. 
With respect to the farmer’s perception of their farm’s 
disease status, the farms were divided into 5 catego-
ries: (1) disease definitely present (based on previous 
laboratory testing or abattoir monitoring); (2) disease 
present but unsure (no previous laboratory testing was 
carried out); (3) disease definitely not present (previ-
ous laboratory testing was carried out); (4) disease not 
present but unsure; and (5) unknown disease status. 
The questionnaire was designed in consultation with 
2 veterinary practitioners and was piloted on 4 farms 
before use. Questions that appeared to be unclear to 
farmers were rephrased to improve the clarity. Inter-
views were carried out by 7 interviewers (3 qualified 
veterinarians and 4 final-year veterinary students), all 
of whom were trained to ensure consistency of the col-
lected data.
Data Analysis
All questionnaire data and the results of the labora-
tory testing were entered into a Microsoft Access 2007 
(Microsoft Corp., Redmond, WA) database. The ac-
curacy of information in the database was crosschecked 
with the questionnaire. All categorical variables were 
summarized using frequencies and percentages. All con-
tinuous variables were checked for deviations from the 
normal distribution using histograms and the normality 
test for skewness and kurtosis. They were summarized 
using frequencies and medians with ranges (minimum 
and maximum). The descriptive statistics were cal-
culated using Stata 11.2 (StataCorp, College Station, 
TX) software.
Prevalence Estimation—Single Disease Test-
ing. For the estimation of prevalence at the herd level, 
the results of assays were dichotomized as positive or 
negative based on the cut-offs summarized, which is 
presented in Table 2. The apparent herd prevalence 
(p) of individual pathogens at the national level was 
calculated as the total number of positive herds divided 
by the total number of herds sampled, weighted to ac-
count for the stratified study design. Sampling weights 
were calculated using the AHDB Dairy sampling frame 
described above (where the dairy cattle population was 
stratified by 6 regions and within each region further by 
3 herd size categories). For each stratum i (i.e., small 
farms in Wales) the sampling weight was calculated as 
1/probability of a farm being selected. The probability 
of a farm being selected in stratum i was calculated 
as several farms studied from stratum i divided by 
the number of registered farms in that stratum. The 
weighted population prevalence (p) and 95% confidence 
intervals were calculated using survey package in Stata 
11.2 according to formulae described in Stata manual 
(StataCorp, 2013). The 95% confidence intervals were 
adjusted by estimating the standard error using linear-
ization method with a first-order Taylor approximation 
of the point estimates (StataCorp, 2013).
The true herd prevalence was calculated for those 
conditions considered biologically meaningful to dichot-
omies herds as not infected or infected and for which 
reliable information on the diagnostic test characteris-
tic for the cut-off were available. The latter information 
included (1) herd-level sensitivity (Se) and specificity 
(Sp) of the diagnostic tests used and (2) a cut-off value 
(as per test manufacturer instruction) to classify herds 
as positive or negative above or below this threshold. 
The point estimates and confidence intervals were 
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adjusted for the Se and Sp of the diagnostic tests as 
described by Rogan and Gladen (1978). Information 
on herd-level Se and Sp of the diagnostic tests, as well 
as the minimum proportion of positive animals for the 
establishment of herd Se and Sp, was obtained either 
directly from the manufacturers or through available 
literature and is summarized in Table 2. In the case of 
the prevalence of O. ostertagi, F. hepatica, N. caninum, 
and C. burnetii, only apparent prevalence is presented, 
as no reliable information on the respective diagnostic 
tests Se and Sp were obtained. All PCR tests were as-
sumed to have 100% Se and Sp. Because of the inability 
of the antibody assays that were performed to distin-
guish between vaccinated and unvaccinated herds, vac-
cinated herds and herds for which vaccination status 
was unavailable were removed from the analysis.
Correlations between studied pathogens in unvac-
cinated herds were assessed by Phi correlation coef-
ficient (ϕ), calculated as the square root of chi-squared 
divided by n, the total number of observations (Olivier 
and Bell, 2013). A chi-squared test was performed to 
assess the association of herd status (positive/negative) 
with region or herd size. Variations in the prevalence, 
taking into account the effect of both region and herd 
size (independent variables), were assessed using lo-
gistic regression, and strength of the associations was 
measured by calculating adjusted odds ratios and their 
confidence intervals (CI). Statistical significance of the 
associations of both independent variables with the 
herd status was tested using a Wald test with α = 5%.
Repeated Quarterly Testing. The apparent and 
true herd prevalence of antibodies against MAP and F. 
hepatica and the presence of BVDV at each quarterly 
test were estimated as described above. Only farms 
that completed all 4 quarterly tests were included in 
the analysis. To estimate overall period prevalence, a 
herd was considered positive if at least 1 of the samples 
tested positive in a given quarterly test during a 12-
mo period. The true period herd prevalence was then 
calculated based on a combined Se and Sp of the tests 
in parallel as Secombined = Se × n − (Se)
n and Spcombined 
= Spn, where n = number of tests carried out. The 
Secombined and Spcombined of MAP ELISA test in parallel 
were calculated as 1.0 and 0.85, respectively. For the 
BVDV PCR test, Secombined and Spcombined of 1 were used.
Farmers’ Perception. Positive and negative pre-
dictive values were calculated as the proportion of 
farms where farmers correctly classified the status of 
the herd with respect to the pathogens under study us-
ing the results of the BMT as the gold standard. Herds 
vaccinated against the studied pathogens or those were 
farmers did not know the status of the tested pathogens 
were excluded from the calculations.
Spatial Analysis
Choropleth maps showing the distribution of posi-
tive herds across the studied regions were generated by 
dividing the number of positive herds by the number 
of herds tested within each region (where possible ad-
justed for the performance of the diagnostic tests used), 
using ArcGIS 10 (ESRI Inc., Redlands, CA) software. 
Presence of spatial autocorrelation was tested using 
the univariate Moran’s I test for global spatial auto-
correlation and Queen contiguity (i.e., considering as 
neighboring units those that have any point such as 
boundaries or corners in common). To account for the 
variation in number of farms tested and the underly-
ing population structure, the prevalence estimates were 
adjusted toward the overall average by applying the 
empirical Bayes smoothing (Anselin, 2004; Anselin et 
al., 2004). Statistical significance of the Moran’s I was 
tested using Monte Carlo randomization with 9,999 
permutations. The analyses of global spatial autocorre-
lation were carried out using the GeoDa 1.6.7 software 
(https:// geodacenter .asu .edu).
Areas with significantly higher or lower proportion 
of BMT-positive herds (clusters) were identified using 
a spatial scanning method, the scan statistic. The test-
ing was performed using Bernoulli probability model 
in SatScan version 9.4.2 (www .satscan .org; Kulldorff, 
1997). The maximum cluster size tested was 50% of 
the population at risk. The geographic information was 
based on the farm postcode (easting and northing co-
ordinates) corresponding to the farm address registered 
within the AHDB Dairy database collected as part of 
the recruitment process. Identified clusters were con-
sidered significant at P < 0.05, based on Monte Carlo 
hypothesis testing with 9,999 permutations. 
The project was approved by the Ethics and Welfare 
committee at the Royal Veterinary College (approval 
number URN 2013 0097H).
RESULTS
Farm Recruitment
Of the 1,483 selected dairy farms, 553 farms re-
sponded (37% response rate), with 279 negative and 
274 positive answers. Of the 274 farms that agreed to 
participate, 225 farms were studied (had milk sample 
tested for some or all of the diseases and completed the 
questionnaire), representing approximately 2% of the 
total population of dairy farms in GB. The remaining 
49 farms that initially answered positively either went 
out of milk production, were no longer contactable, 
or were no longer interested in the study for various 
reasons.
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Farm Characteristics
The median herd size was 133 adult cows and ranged 
from 14 to 603. Approximately half (117/225) of the 
farms were mixed dairy farms (dairy farms with other 
production animals; i.e., beef or sheep), and the ma-
jority of the farms (93%, 209/225) were conventional 
(as opposed to organic) dairy producers. One hundred 
sixty-four farms (73%) managed their milking herd as 
1 production group, and the remaining farms had 2 
or more groups of high- and low-yielding cows. The 
average milk yield per cow per year in 2013 was 7,613 
L (median = 7,822, range = 3,100–11,679 L). Infor-
mation on calving intervals was recorded from 205 
farms with median of 406 d (range = 310–474 d). On 
the majority of farms cows calved year round (74%, 
165/224). The most common grazing system was graz-
ing in summer and housed in winter (89%, 200/225). 
On 13 (6%) farms, cows were kept indoor year round; 
on the remaining farms, cows were kept outdoor year 
round. Cubicles (i.e., freestalls) were the most common 
(79%, 164/208) type of housing for milking cows, with 
27 (13%) farms housing milking cows in straw yards 
and the remaining farms using both type of housing. 
One hundred seven farms (48%) purchased new cattle 
during a 12mo period before the farm visit.
Point Prevalence
Initial BMT samples were obtained for all farms 
between July 2014 and March 2015, with 144 farms 
(64%) tested between July and September 2014. The 
estimated herd prevalence of the studied pathogens 
based on the presence of antibodies (on unvaccinated 
farms) or antigen (all farms) in the initial BMT samples 
was high, with a higher proportion of positive herds 
found among medium (50–150 cows) and large (≥150 
cows) herds (Table 3). The true prevalence of antibody-
positive unvaccinated herds ranged from 48 (95% CI: 
40–56) to 68% (95% CI: 61–76) for Salmonella spp. and 
MAP, respectively. Of the 9 BVDV antigen-positive 
herds, 7 vaccinated against BVDV. Among BVDV 
unvaccinated herds, 2 herds were both BVDV antigen- 
and antibody-positive. Of the 57 C. burnetii antigen-
positive herds, 55 herds had also antibodies detected. 
The distribution of ELISA antibody levels, expressed 
as percent positivity or percent inhibition (BVDV), is 
presented in Figure 1. Of the pathogens tested, among 
unvaccinated herds, a correlation of positive status was 
found between (1) BVDV antibody and BHV-1, Lepto-
spira Hardjo, and F. hepatica; (2) BHV-1 and MAP and 
Leptospira Hardjo; and (3) C. burnetii antibody- and 
antigen-positive herds (Table 4). Correlation between 
BVDV antibody and antigen positivity was very low. Ta
b
le
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Associations of Prevalence with Region  
and Herd Size
In the univariable analysis, herd-level prevalence 
differed among regions for BVDV antibody (P = 
0.01), BVDV antigen (P = 0.03), Leptospira Hardjo 
(P < 0.001), MAP (P = 0.04), Salmonella spp. (P = 
0.001), C. burnetii antibody (P = 0.01), Chlamydia-like 
organisms (P = 0.04), and F. hepatica (P < 0.001). 
Differences in herd-level prevalence by herd size were 
also observed for C. burnetii antibody (P < 0.001), F. 
hepatica (P = 0.02), and O. ostertagi (P = 0.05).
Accounting for the effect of herd size, regional varia-
tions in herd-level prevalence remained apparent for 
Figure 1. Results of antibody titers on unvaccinated farms detected by serological testing of bulk milk samples between July 2014 and March 
2015, interpreted as a percent positivity or percent inhibition (for bovine viral diarrhea virus). The blue vertical line indicates cut-offs for nega-
tive or positive ELISA results. BVD = bovine viral diarrhea virus; MAP = Mycobacterium avium ssp. paratuberculosis; BHV-1 = bovine herpes 
virus 1. Color version available online.
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most of the studied pathogens (Table 5). Herds located 
in Wales and Scotland had higher odds of being positive 
to BVDV antibody, BHV-1, Leptospira Hardjo, Sal-
monella spp., and F. hepatica. Herds located in south-
west England had the highest odds of being positive 
for MAP and C. burnetii compared with the herds in 
southeast England. Accounting for the effect of region, 
large herds (≥150 cows) had increased odds of being 
positive to Salmonella spp. and C. burnetii (Table 5) 
compared with the small herds (<50 cows). The BVDV 
antigen and O. ostertagi could not be included in the 
multivariable analysis due to omitted observations in 
some of the categories of region or herd size.
Repeated Quarterly Testing
The quarterly testing for the presence of BVDV an-
tigen and antibodies against MAP and F. hepatica in 
BMT samples was carried out between October 2014 
and November 2015. The median interval between the 
second, third, and fourth quarterly test was 90, 92, 
and 89 d, respectively, with a minimum of 19 d and 
a maximum of 190 d between any 2 tests carried out. 
The overall prevalence of BVDV and antibodies against 
MAP and F. hepatica in bulk milk, based on all 4 tests 
results, was estimated for 203, 206, and 206 farms, re-
spectively. The results of prevalence at each quarterly 
testing as well as the overall (period) prevalence dur-
ing the whole study period are presented in Figure 2. 
The true prevalence of BVDV antigen-positive herds 
was 5, 11, 11, and 12% and of MAP antibody-positive 
farms was 68, 72, 83, and 80% at each quarterly test, 
respectively. The apparent prevalence of F. hepatica an-
tibody-positive herds at first, second, third, and fourth 
test was 55, 60, 57, and 56%, respectively. During the 
whole study period, the true prevalence of herds testing 
positive at least once to BVDV antigen or antibodies 
against MAP was 19 (95% CI: 13–26%) and 89% (95% 
CI: 81–94%), respectively; the apparent period preva-
lence of F. hepatica was 67% (95% CI: 61–73%).
Farmers’ Knowledge of Disease Status
Approximately 19% (42/224) of farms were members 
of 1 of the accredited herd health schemes, and 3% 
(7/224) of farms were working toward membership at 
the time of the visit. Farmers’ knowledge of the status 
of their herds with respect to the studied pathogens is 
summarized in Figure 3. Among unvaccinated herds, 
farmers believed MAP, F. hepatica, and BVDV to be 
present on 55, 46, and 30% of farms, respectively. Of 
the studied pathogens, the most frequently reported 
problems were due to MAP (41% of farms), whereas 
no problems due to Salmonella spp., C. burnetii, or O. Ta
b
le
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ostertagi were reported (Figure 3). The percentage of 
herds where farmers correctly believed the disease in 
question was present that actually tested positive (posi-
tive predictive value) was high for C. burnetii (100%; 
although more than 50% of the farmers did not know 
the status), O. ostertagi (97%), and BVDV antibody 
(92%), but very low for BVDV antigen (5%; Table 6). 
High negative predictive value of the farmers’ percep-
tion was estimated for BVDV antigen (96%).
Spatial Distribution
Accounting for the vaccination status, herds that 
tested positive for the individual pathogens were found 
in all studied regions. However, the variation in the 
distribution of the positive herds was marked across the 
regions (Figure 4 a–c) with the lowest estimates found 
mostly in southeast England. Global spatial autocor-
relation of positive unvaccinated herds was detected for 
Figure 2. (a) The estimated point and overall (period) true prevalence of antibodies against Mycobacterium avium ssp. paratuberculosis 
(MAP) and bovine viral diarrhea virus (BVDV) antigen and 95% CI of estimates tested using the bulk tank milk samples as part of the cross-
sectional study (n = 225 dairy farms in Great Britain studied between July 2014 and November 2015). For Fasciola hepatica, the estimates and 
95% CI of apparent prevalence are presented. Dynamics of tested pathogens (b) expressed as proportion of old and new positive farms of the 
total number of positive farms detected at each quarterly test compared with the previous test result of a given pathogen; and (c) proportion of 
farms that tested always positive, changed between positive or negative, or always tested negative during the whole study period (July 2014 to 
November 2015). Color version available online.
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BVDV antibodies (I = 0.23, P = 0.02), F. hepatica (I 
= 0.22, P = 0.008), and Salmonella spp. (I = 0.18, P 
= 0.02). Spatial autocorrelation of C. burnetii PCR-
positive herds was also detected (I = 0.03, P = 0.02). 
By means of the scan statistic, both low- and high-risk 
clusters of positive unvaccinated herds were found for 
F. hepatica, Leptospira Hardjo, Salmonella spp., and 
for BVDV antibodies. Further, 1 high-risk cluster for 
BVDV antigen and O. ostertagi and 1 low-risk clus-
ter for C. burnetii antibody-positive herds were found 
Figure 3. Farmers’ perception of the herd disease status at the time of the visit before the laboratory testing of bulk milk samples being 
carried out accounted for the vaccination status. “Believed as present” represents farms where farmers knew the disease was present based on the 
results of previous test or based on their perception. “Believed as problem” represents farms where farmers believed that the listed disease was 
a problem at the time of the visit. “Antibody test positive” represents the true proportion of positive unvaccinated farms based on the detection 
of antibodies against tested pathogens using single bulk tank milk samples collected between July 2014 and March 2015 (n = 225 dairy farms in 
Great Britain). BVD = bovine viral diarrhea virus; MAP = Mycobacterium avium ssp. paratuberculosis; BHV-1 = bovine herpes virus 1. Color 
version available online.
Table 6. Farmers’ perception1 of the disease status expressed as positive (PPV) and negative predictive values 
(NPV) using the bulk milk results as the gold standard
Pathogen2 and type of test  
(antigen or antibody detection  
in bulk milk sample)  Subset
Farmers’ perception  
of current disease status
n3 PPV % NPV %
BVDV (antigen) All farms 202 5.0 95.9
BVDV (antibody) Unvaccinated 92 92.3 53.0
MAP (antibody) Unvaccinated 204 70.7 51.0
Leptospira Hardjo (antibody) Unvaccinated 98 75.0 70.5
Bovine herpes virus-1 (antibody) Unvaccinated 93 75.0 46.6
Salmonella spp. (antibody) Unvaccinated 157 68.7 63.2
Coxiella burnetii (antibody) All farms 75 100.0 31.5
Coxiella burnetii (antigen) All farms 75 100.0 80.8
Fasciola hepatica (antibody) All farms 192 64.9 73.5
Neospora caninum (antibody) All farms 165 61.3 63.1
Ostertagia ostertagi (antibody) All farms 166 97.2 7.5
1The perception was recorded at the time of the visit before the single laboratory testing of the bulk milk 
samples carried out as part of the cross-sectional study of 225 dairy farms in Great Britain carried out between 
July 2014 and March 2015.
2BVDV = bovine viral diarrhea virus; MAP = Mycobacterium avium ssp. paratuberculosis.
3n = number of farms. Farms on which the disease status was unknown were excluded from the calculation of 
the PPV and NPV.
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(Figure 5 a,b). All low-risk clusters were located in 
southeast England.
DISCUSSION
To inform decisions regarding disease priorities and 
suitable control programs and to allow for monitoring 
of disease trends over time, reliable and up-to-date 
information on disease prevalence is highly desirable. 
With this in mind, the present study was designed 
to provide prevalence estimates representative of the 
national GB dairy herd for several nonstatutory infec-
tious diseases assumed endemic. Bovine tuberculosis, 
although identified as important during the workshop, 
was not included in the study due to the fact that exist-
ing mandatory surveillance provides reliable informa-
tion on its occurrence at the national level (Velasova 
et al., 2015). Participation in the study was voluntary; 
however, when compared nationally, although the es-
timated weighted average herd size of 187 cows was 
slightly higher than that of 144 cows for the GB dairy 
herd, the estimated average annual milk yield was com-
parable with the national estimate of 7,535 L (DairyCo, 
2013). This suggests that the data were not noticeably 
biased in this respect. The use of stratified sampling 
by region and herd size further allowed us to produce 
national prevalence estimates with smaller standard er-
rors compared with a nonstratified study of the same 
size.
The results of high prevalence and wide geographic 
distribution confirm that the studied pathogens are 
spread widely across GB and that, at the time of the 
study, a large proportion of the dairy herds in GB had 
previously been exposed to them. The high prevalence 
levels further suggest that active disease transmission is 
occurring among the dairy cattle population and that 
available control measures are either not being imple-
mented or not being effective. The estimated prevalence 
values of most of the studied pathogens broadly agree 
with those reported from other countries, where these 
pathogens are considered endemic, suggesting similar 
pathogen dynamics [BVDV and BHV-1 (Kampa et 
al., 2004; Sayers et al., 2015; Fernandes et al., 2016), 
MAP (Muskens et al., 2000; van Schaik et al., 2003), 
C. burnetii (van Engelen et al., 2014), Salmonella spp., 
and Leptospira Hardjo (Habing et al., 2012; O’Doherty 
et al., 2013). Higher-prevalence estimates of F. hepatica 
(Cringoli et al., 2002; Olsen et al., 2015) and N. cani-
num infections were estimated in our study compared 
with some other countries (Sanderson et al., 2000; 
O’Doherty et al., 2013).
Bulk milk samples were used to assess herd status 
based on the presence of specific antibodies or antigen. 
Our prevalence estimates are therefore herd-level esti-
mates and they are subject to misclassification bias as 
a result of imperfect Se or Sp of the tests applied at the 
level of the herd. Ascertainment of the infection status 
of a herd by means of testing a single milk sample from 
the bulk tank is well established and has obvious logis-
tical and financial advantages. On the other hand, the 
use of bulk milk comes with limitations, as the ability 
to identify infected herds (sensitivity) is compromised, 
in particular for pathogens that can be present in the 
herd at low levels. In this situation, negative results 
should be interpreted as a herd with less than a mini-
mum proportion of positive animals among those in 
milk needed for the expected ability of the diagnostic 
test to classify herd as positive. When possible, we tried 
to adjust the apparent prevalence obtained for the im-
perfect performance of the test using available values 
of herd-level Se and Sp. This information was, however, 
not available for some of the studied pathogens, such as 
C. burnetii, F. hepatica, N. caninum, and O. ostertagi. 
As a result, only estimates of their apparent prevalence 
are presented. In addition, we assumed all PCR tests 
to have 100% Se and Sp, which could have resulted 
in the misclassification bias. Another limitation is that 
the antibodies detected in BMT sample may be indica-
tive of historical rather than active or recent infection 
(Lindberg and Alenius, 1999; Booth et al., 2013; Sayers 
et al., 2015), and that the bulk milk sample does not 
include the whole herd. Young stock, clinically ill cows, 
and dry cows were excluded from the sample. As a 
result, for example, the prevalence of BVDV antigen 
in bulk milk can be underestimated due to premature 
culling of infected young stock (Bishop et al., 2010). 
Similarly, the prevalence of MAP can be underestimat-
ed due to the susceptibility of cows infected with MAP 
to secondary conditions (e.g., mastitis or lameness; Vil-
larino and Jordan, 2005) and the subsequent exclusion 
of cows treated with antibiotics from milk sampling and 
testing. Furthermore, exclusion of the vaccinated herds 
from the study population resulted in lower precision of 
the prevalence estimates, such that the smallest num-
ber of the studied unvaccinated herds (102 herds) was 
sufficient to estimate 50% prevalence (the worst-case 
scenario) with 10% precision and 95% confidence.
Regional variations in prevalence of some of the 
studied pathogens have been reported previously (Ryan 
et al., 2012; Howell et al., 2015; Sayers et al., 2015). 
Overall, we found a lower proportion of positive herds 
in southeast England, where cattle density is lower 
(<10 dairy cows per 100 ha of farmed land) compared 
with the other studied regions (CHAWG, 2012). Other 
factors, such as herd size, management practices (bi-
osecurity, purchase of new stock), and environmental 
conditions (i.e., temperature, type of land), can be 
used to explain the observed regional differences in the 
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number of positive herds. However, comparison at re-
gional level has to be done with caution, as the present 
national study was not designed to generate prevalence 
estimates at regional level.
A relatively high number of studied farms were vac-
cinated against BVDV, BHV-1, and Leptospira Hardjo, 
which indicates farmers’ understanding of a need for 
disease control measures. Only the results of unvac-
cinated herds are presented, as the diagnostic tests 
used in our study were unable to differentiate between 
vaccinated and infected herds. The presence of a cor-
relation between the positive status for BVDV antibod-
ies, BHV-1, Leptospira Hardjo, MAP, and F. hepatica 
suggests similar risk factors for infections due to these 
pathogens, which is in agreement with the previous 
reports (Paton et al., 1998; Kampa et al., 2004; Wil-
liams and Winden, 2014). The high level of antibodies 
against BVDV and BHV-1 detected in several herds is 
suggestive of the presence of active infection or in case 
of BVDV, also presence or recent removal of persis-
tently infected animal(s) (Kampa et al., 2004; Booth et 
al., 2013). However, the detection of a low positive cor-
relation between BVDV antibody and antigen positive 
herds in our study is indicative of detection of historical 
infections on several farms, as the antibodies can persist 
in bulk milk up to 3 to 4 yr in previously infected herds 
(Lindberg and Alenius, 1999). The observed variation in 
the level of BHV-1 BMT antibody detected agrees with 
the previous report of herds being either strongly posi-
tive or with very low or no antibody detected (Paton 
et al., 1998). Furthermore, the estimated prevalence of 
BHV-1 is almost identical to the values reported from 
previous surveys, indicating the stability of the virus in 
the population of GB dairy herds (Paton et al., 1998; 
Williams and Winden, 2014).
The high apparent prevalence of BMT antibodies 
against O. ostertagi, F. hepatica, and N. caninum is 
not surprising. It has been reported that O. ostertagi 
is present in all herds and that the majority of type 
1 ostertagiosis infections occur during summer months 
(Sekiya et al., 2013). Higher proportions of O. ostertagi 
and F. hepatica BMT antibody-positive herds were 
found in the northern parts of GB. This is most likely 
due to the effect of environmental factors (i.e., higher 
rainfall in these regions in 2014; MetOffice, 2014) as 
well as differences in grazing practices (i.e., access to 
pasture and duration of grazing; Sekiya et al., 2013). In 
relation to N. caninum, seasonal variation in the preva-
lence has been previously reported (O’Doherty et al., 
2013). Due to limited financial resources in our study, 
only a single testing was carried out, which could have 
resulted in some positive herds being missed, especially 
on farms tested during early stages of the lactation 
(O’Doherty et al., 2013). However, in our study the 
majority of the herds (74%) were calving year round. 
Furthermore, the first testing was carried out between 
July 2014 and March 2015, with the majority (64%) of 
the samples tested between July and September 2014 
minimizing the number of false-negative results on 
farms with seasonal calving.
The prevalence of Salmonella spp. and C. burnetii in 
a population of dairy herds in GB was high. However, 
no farmer reported problems due to these pathogens, 
indicating that they are mostly subclinical or unrec-
ognized. It further suggests that the importance of a 
pathogen or disease and willingness to act on depend 
not just on prevalence but also on attributable eco-
nomic effects. As a result, without routine screening, 
infected herds will remain undetected and pose a 
risk for disease transmission, especially in areas with 
high cattle density. The differences in environmental 
and climatic conditions (i.e., type of landscape, cattle 
density, temperature, rainfall, wind) were also reported 
to play an important role in relation to the regional 
variations we observed for these pathogens (Davison 
et al., 2005; Nusinovici et al., 2015). Similarly, diverse 
ecological niches and a wide hosts range for Chlamydia-
like organisms have been reported (Taylor-Brown et al., 
2015). In addition to their presence in environment, 
previous studies in GB have also observed the evidence 
of Chlamydia-like organisms in 18% of bovine placenta 
samples in Scotland (Wheelhouse et al., 2012) and in 
approximately 10% of bovine samples in England and 
Wales (Wheelhouse et al., 2015).
The repeated testing for BVDV antigen and antibod-
ies against MAP and F. hepatica allowed us to observe 
trends in antibody levels. The exposure of herds to F. 
hepatica appeared to be stable during the whole follow-
up period, suggesting the endemicity of the infection 
on the farms. In relation to MAP infections, changes 
from positive to negative or negative to positive status 
were observed in more than half of the herds during 
the follow up period. The changes could be due to the 
low sensitivity of the MAP ELISA (van Weering et al., 
2007), purchase of seropositive animals on open farms, 
or exclusion of dry or seropositive animals from the 
BMT testing. Changes in BVDV antigen status during 
the study period could also be due to a purchase or 
removal of infected animals from the herd or bulk milk 
sample at the time of the testing or due to a persistently 
infected heifer entering the milking herd (Booth and 
Brownlie, 2012). The observed changes in prevalence of 
BVDV antigen and antibodies against MAP, together 
with the results of farmers’ perception of disease status, 
highlight the importance and value of repeated testing 
in correctly identifying infected herds and, hence, ap-
propriate control measures.
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Given the importance of accurate and reliable base-
line data for the effective implementation and monitor-
ing of disease control programs, the results of our study 
are particularly valuable. That is because the results 
of our study not only provide much-needed baseline 
data for the control of endemic pathogens (for which 
monitoring is already underway in GB; i.e., BVDV), 
but also for other pathogens that are not presently be-
ing monitored at the national level in GB.
CONCLUSIONS
Dairy herds in GB are frequently exposed to several 
endemic pathogens that are prevalent at high levels and 
exhibit some geographical variations. Given the bur-
den to efficient production that those pathogens pose, 
and in some cases their public health implications, the 
implementation of measures to control and possibly 
eliminate some of these pathogens should be given 
consideration. Despite some limitations, the prevalence 
figures estimated in this study provide a basis for the 
future monitoring of disease trends over time and can 
be used to assess the effectiveness of future disease con-
trol programs implemented at the national level.
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